Results 141 to 150 of about 557,947 (269)

The organ-specific modulation of malignant processes by opioids: a systematic review of cell culture studies. [PDF]

Br J Cancer
Hefteh N, Welch O, Sheikh M, La Caze A, Parat MO.   +4 more
europepmc   +1 more source

NARCOTIC ANTAGONIST ACTIVITY OF THE 3-PHENYL-PIPERIDINES WITH N-ANTAGONISTIC SUBSTITUTION

, 1973
Seiichi Nurimoto, Goro Hayashi
openalex   +1 more source

Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder. [PDF]

Addict Sci Clin Pract
Lira MC, Hendy LE, Liakas A, Turanchik L, Pritchard C, Jimes C, Justin Coffey M.   +6 more
europepmc   +1 more source

Reversing effects of narcotic antagonists to narcotic immobilizing agents in zoo animals.

, 1986
Etsuo NARUSHIMA
openalex   +2 more sources

Buprenorphine Dispensing after Elimination of the Waiver Requirement. [PDF]

N Engl J Med
Chua KP, Bicket MC, Bohnert ASB, Conti RM, Lagisetty P, Nguyen TD.   +5 more
europepmc   +1 more source

Perioperative pain management interventions in opioid user patients: an overview of reviews. [PDF]

BMC Anesthesiol
Vadeghani AT, Grant M, Forget P.
europepmc   +1 more source

Government publications – resources on drug information [PDF]

, 1977
Whitlatch, Jo Bell
core   +1 more source

Electroencephalographical analysis of narcotic antagonistic action of naloxone or naltrexone

, 1981
Toshio Ishikawa, Kazushi Yamanouchi, Seiji Nemoto, Yuji Tanaka, Ryuya Yanagihashi, Etsuko Saita, Keiko Nakagaki   +6 more
openalex   +1 more source

Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study.

JMIR Res Protoc
Muhamad NA, Ma'amor NH, Muhamad Rasat MA, Tengku Baharudin Shah TPN, Rosli '', Leman FN, Jamalluddin NH, Misnan NS, Chemi N, Abdullah N, Ibrahim N, My Addiction Study group.   +11 more
europepmc   +1 more source